The impact of different ovarian stimulation protocols on embryological stage and efectiveness of ivf cycles

The impact of different ovarian stimulation protocols on embryological stage and efectiveness of ivf cycles

There are controversial data about the effect of different controlled ovarian hyperstimulation (COS) protocols on embryological stage and in vitro fertilization (ivf) outcomes. The aim of our study was to evaluate embryological and clinical outcomes according to COS protocol.Material and methods. Th...

Full description

Bibliographic Details
Main Authors:	M G Andreeva, A G Syrkasheva, N V Dolgushina, E A Kalinina
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2016-02-01
Series:	Гинекология
Subjects:	artificial reproductive technologies controlled ovarian stimulation in vitro fertilization gnrh antagonists gnrh agonists ivf in natural cycle corifollitropin alfa
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/28524/pdf

Similar Items

OVARIAN STIMULATION FOR IVF-ET PROCEDURE
by: Robert Medved, et al.
Published: (2002-03-01)

Use of Corifollitropin Alfa for Ovarian Stimulation: A Retrospective Analysis of 804 Women Undergoing IVF/ICSI
by: Nhu H. Giang, et al.
Published: (2019-06-01)

Flexible Multi-dose GnRH Antagonist versus Long GnRH Agonist Protocol in Poor Responders: A Randomized Controlled Trial
by: Ensieh Shahrokh Tehraninejad, et al.
Published: (2009-02-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)

Klinische Studien/Klinische Praxis: Expertenkommentar zur Metaanalyse "Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis"
by: Just A
Published: (2015-01-01)

Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation
by: Yu Li, et al.
Published: (2012-01-01)

GnRH Agonist Triggering of Ovulation Replacing hCG: A 30-Year-Old Revolution in IVF Practice Led by Rambam Health Care Campus
by: Shahar Kol, et al.
Published: (2017-04-01)

Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles
by: Yao Lu, et al.
Published: (2021-03-01)

The Effect of Coasting on Intracytoplasmic Sperm Injection Outcome in Antagonist and Agonist Cycle
by: Z.Candan İltemir Duvan, et al.
Published: (2017-04-01)

Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve
by: Wanlin Zhang, et al.
Published: (2020-05-01)

Risk factors of poor ovarian response in IVF practice
by: R E Vanyan, et al.
Published: (2014-10-01)

The aptness of antagonistic protocol in intracytoplasmic sperm injection: Embryologic study
by: Tuqa Yousif Sharef
Published: (2019-04-01)

Prolonged GnRH suppression period in controlled ovarian hyperstimulation cycles: Impacts on IVF outcomes?
by: Ozlem Gun Eryilmaz, et al.
Published: (2012-01-01)

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Shan Liu, et al.
Published: (2021-07-01)

Nimodipine, a calcium channel blocker, delays the spontaneous LH surge in women with regular menstrual cycles: a prospective pilot study
by: Nayot Dan, et al.
Published: (2013-02-01)

Corifollitropin alfa for poor responders patients, a prospective randomized study
by: F. M. Fusi, et al.
Published: (2020-07-01)

Impact of different controlled ovarian stimulation protocols on the physical and psychological burdens in women undergoing in vitro fertilization/intra cytoplasmic sperm injection
by: Deenadayal Mamata, et al.
Published: (2015-01-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010-09-01)

Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study
by: Minghui Chen, et al.
Published: (2020-05-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve
by: Zakia Mahdy Ibrahim, et al.
Published: (2011-12-01)

Avaliação da estimulação ovariana com uso de análogos do gnrh
by: Montenegro, Ivan Sereno
Published: (2012)

Avaliação da estimulação ovariana com uso de análogos do gnrh
by: Montenegro, Ivan Sereno
Published: (2012)

Avaliação da estimulação ovariana com uso de análogos do gnrh
by: Montenegro, Ivan Sereno
Published: (2012)

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
by: Dan Zhang, et al.
Published: (2018-12-01)

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve
by: Ming-Huei Lin, et al.
Published: (2019-01-01)

Corifollitropin alfa in different variants of ovarian response in assisted reproductive technology programmes: literature review
by: A. G. Syrkasheva, et al.
Published: (2021-04-01)

Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women
by: Yung-Ling Chang, et al.
Published: (2006-12-01)

Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT
by: Ensieh Shahrokh Tehrani Nejad, et al.
Published: (2018-08-01)

Cost-effectiveness of different types of COH protocols for in vitro fertilization at national level
by: Boriana Benbassat, et al.
Published: (2017-01-01)

GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012-04-01)

Corifollitropin alfa versus follitropin beta: an economic analysis alongside a randomized controlled trial in women undergoing IVF/ICSI
by: Le Dang Khoa, et al.
Published: (2020-06-01)

Priming with a gonadotropin-releasing hormone agonist before immature oocyte retrieval may improve maturity of oocytes and outcome in in vitro maturation (IVM) cycle: a case report
by: A. Smirnova, et al.
Published: (2021-03-01)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
by: Andrea Roberto Carosso, et al.
Published: (2021-03-01)

Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study
by: Li-Hong Wei, et al.
Published: (2016-02-01)

Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study
by: Jie Lan, et al.
Published: (2021-05-01)

Anovulatory Patients Demonstrate a Sharp Decline in LH Levels upon GnRH Antagonist Administration during IVF Cycles
by: Linoy Segal, et al.
Published: (2017-04-01)

Impact of Prolonged Versus OCP Plus Long Protocol on IVF-ET Outcomes in Patients With Grade III-IV Endometriosis: A Randomized Clinical Trial
by: Ladan Kashani, et al.
Published: (2018-05-01)

Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients
by: Sills E, et al.
Published: (2012-08-01)